Alnylam Pharmaceuticals | ALNY - 市值

金融业

USD

USD 5.13B

现金及等价物

USD 1.71B

USD 211.12M

USD 4.22B

USD 1.35B

USD 1.28B

USD 137.59M

USD 145.22M

2.23K

EPS每股收益

USD 1.99

股本和储备

USD 1.08B

USD 825.01M

债务利息支出

USD 69.29M

USD 26.63M

USD 2.48B

USD 38.13B

USD 205.99M

USD 898.54M

USD 137.59M

普通股股本

USD 133.44M

80.04

USD 221.65M

USD 1.17B

销售和管理费用

USD 282.51M

USD 200.15M

贸易债权人

USD 126.63M

应收帐款人

USD 883.96M

	市值	更改		日
Acadia Pharmaceuticals	USD 3.57B		221M	2026-05
Agios Pharmaceuticals	USD 2.01B		423M	2026-03
Alnylam Pharmaceuticals	USD 44.15B		8.39B	2026-03
Amgen	USD 189.89B		13.64B	2026-03
Arrowhead Research	USD 9.7B		920M	2026-05
BioCryst Pharmaceuticals	USD 1.66B		64M	2025-12
BioMarin Pharmaceutical	USD 10.18B		683M	2026-05
Incyte	USD 21.73B		3B	2026-05
Ionis Pharmaceuticals	USD 12.46B		356M	2026-03
Moderna	USD 20.15B		8.53B	2026-03
Neurocrine Biosciences	USD 15.15B		1.9B	2026-05
PTC Therapeutics	USD 4.94B		698M	2026-05
Regeneron Pharmaceuticals	USD 81.68B		560M	2026-03
Sarepta Therapeutics	USD 2.16B		123M	2026-05
Takeda	JPY 8.33T		681.01B	2026-05
Tectonic Therapeutic	USD 390M		96M	2025-12
Ultragenyx Pharmaceutical	USD 2.06B		1000K	2026-05
Vertex Pharmaceuticals	USD 113.58B		1000K	2026-05
Xencor	USD 795M		98M	2026-05